ABSTRACT
Digital health (DH) is driving a paradigm shift in health care that is transforming the way in which health services are delivered and received. DH applications are creating significant opportunities for health care stakeholders to improve patient outcomes, reduce unnecessary costs, and create additional value. To reap the benefits, multiple organizations, including pharmaceutical companies, hospitals, public and private payers, patient advocacy groups, traditional technology companies, and health technology companies, among others, have sought to develop and incorporate DH tools. Although DH has great potential value in oncology, the adoption of DH solutions in this area has been relatively low compared with other disease areas, such as diabetes and cardiovascular disease. This report outlines definitions of four promising categories of DH solutions in oncology and presents in-depth analyses of the current state of each category of solution. By piecing together the fragmented oncology DH market, the key drivers of successful DH solutions are illuminated, along with the actions needed to more effectively realize their future impact and value within oncology.